1010096-65-7

1010096-65-7 structure

Name: 2H-Tetrazole-2-carboxamide, 5-([1,1'-biphenyl]-4-ylmethyl)-N,N-dimethyl-
Chemical Name: 5-[(1,1'-biphenyl)-4-ylmethyl]-N,N-dimethyl-2H-tetrazole-2-carboxamide
CAS Number: 1010096-65-7
Molecular Formula: C₁₇H₁₇N₅O
Molecular Weight: 307.35
Catalog: Signaling Pathways Metabolic Enzyme/Protease FAAH
Create Date: 2016-06-04 15:39:28
Modify Date: 2025-08-25 11:11:11
AM6701 is a potent FAAH/MAGL inhibitor (equipotent inhibitory IC50: 1.2 nM) with neuroprotective effects[1].

Name	5-[(1,1'-biphenyl)-4-ylmethyl]-N,N-dimethyl-2H-tetrazole-2-carboxamide
Synonyms	5-(4-Biphenylylmethyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide 5-Biphenyl-4-yl-2-phenyl-oxazol 2H-Tetrazole-2-carboxamide, 5-([1,1'-biphenyl]-4-ylmethyl)-N,N-dimethyl-

Description	AM6701 is a potent FAAH/MAGL inhibitor (equipotent inhibitory IC50: 1.2 nM) with neuroprotective effects[1].
Related Catalog	Signaling Pathways >> Metabolic Enzyme/Protease >> MAGL Signaling Pathways >> Metabolic Enzyme/Protease >> FAAH Research Areas >> Neurological Disease Signaling Pathways >> Neuronal Signaling >> FAAH
Target	IC50: 1.2 nM (FAAH/MAGL)[1]
References	[1]. Vinogran Naidoo, et al.Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology.Neurotherapeutics.2012 Oct;9(4):801-13.